| Serial Number | 87323886 |
| Word Mark | TANVEX BIOPHARMA |
| Filing Date | Friday, February 3, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 25, 2021 |
| Registration Number | 6358661 |
| Registration Date | Tuesday, May 25, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 9, 2021 |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| Goods and Services | Anti-arthritis preparations; anti-inflammatory agent; anticancer drug; antirheumatic preparations; medicines for human purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; western medicines for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; medicinal agent for human use, namely, medicinal herbal preparations; biological preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; haematogen, namely, blood substitutes for human use; chemical preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical drugs for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical preparations for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 8, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tanvex BioPharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Grand Cayman KY1-1205 KY |
| Party Name | Tanvex BioPharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Grand Cayman KY1-1205 KY |
| Party Name | Tanvex BioPharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Grand Cayman KY1-1205 KY |
| Event Date | Event Description |
| Tuesday, May 25, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 9, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 9, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 17, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 3, 2021 | CASE RETURNED TO EXAMINATION |
| Monday, January 4, 2021 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, February 2, 2021 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
| Monday, January 4, 2021 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Monday, January 4, 2021 | ASSIGNED TO PETITION STAFF |
| Friday, December 18, 2020 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Wednesday, August 12, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 11, 2020 | EXTENSION 5 GRANTED |
| Wednesday, July 1, 2020 | EXTENSION 5 FILED |
| Wednesday, July 22, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, July 1, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, July 1, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, July 1, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 1, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, July 1, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, July 1, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 1, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 31, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 27, 2019 | EXTENSION 4 GRANTED |
| Friday, December 27, 2019 | EXTENSION 4 FILED |
| Friday, December 27, 2019 | TEAS EXTENSION RECEIVED |
| Monday, July 8, 2019 | ASSIGNED TO EXAMINER |
| Friday, June 7, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 5, 2019 | EXTENSION 3 GRANTED |
| Wednesday, June 5, 2019 | EXTENSION 3 FILED |
| Wednesday, June 5, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, December 26, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 24, 2018 | EXTENSION 2 GRANTED |
| Monday, December 24, 2018 | EXTENSION 2 FILED |
| Monday, December 24, 2018 | TEAS EXTENSION RECEIVED |
| Friday, May 4, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 2, 2018 | EXTENSION 1 GRANTED |
| Wednesday, May 2, 2018 | EXTENSION 1 FILED |
| Wednesday, May 2, 2018 | TEAS EXTENSION RECEIVED |
| Wednesday, May 2, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 2, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 7, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 7, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 18, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 5, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, October 2, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 23, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, September 23, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 20, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, May 6, 2017 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Saturday, May 6, 2017 | PRIORITY ACTION E-MAILED |
| Saturday, May 6, 2017 | PRIORITY ACTION WRITTEN |
| Saturday, April 29, 2017 | ASSIGNED TO EXAMINER |
| Thursday, March 30, 2017 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Friday, March 10, 2017 | ASSIGNED TO LIE |
| Thursday, February 23, 2017 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, February 8, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, February 7, 2017 | NEW APPLICATION ENTERED IN TRAM |